EUVIMEDEUVIMED entdecken
Crossref

Factors associated with the development of coronary artery disease in people with HIV

Ari S Mushin, Janine M Trevillyan, Sue J Lee, Anna C Hearps, Jennifer F Hoy

Sexual Health · 11.10.2023 · 20 (5) · 470-474

DOI: 10.1071/sh23043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sexual Health, online erschienen am 03.07.2023. Verfasst von Ari S Mushin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Monash University, Melbourne, Vic., Australia. Hauptthemen laut MEDLINE: HIV Infections, Coronary Artery Disease, Hypertension. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People living with HIV (PLHIV) are at increased risk for coronary artery disease (CAD). This study aimed to describe the features associated with CAD in PLHIV.

Methods

A case ([n = 160] PLHIV with CAD) control ([n = 317] PLHIV matched by age and sex without CAD) study was performed at the Alfred Hospital, Melbourne, Australia (January 1996 and December 2018). Data collected included CAD risk factors, duration of HIV infection, nadir and at-event CD4+ T-cell counts, CD4:CD8 ratio, HIV viral load, and antiretroviral therapy exposure.

Results

Participants were predominantly male (n = 465 [97.4%]), with a mean age of 53 years. Traditional risk factors associated with CAD in univariate analysis included hypertension (OR 11.4 [95%CI 5.01, 26.33], P < 0.001), current cigarette smoking (OR 2.5 [95% CI 1.22, 5.09], P = 0.012), and lower high-density lipoprotein cholesterol (OR 0.14 [95%CI 0.05, 0.37], P < 0.001). There was no association between duration of HIV infection, nadir or current CD4 cell count. However, current and ever exposure to abacavir (cases: 55 [34.4%]; controls: 79 [24.9%], P = 0.023 and cases: 92 [57.5%]; controls: 154 [48.6%], P = 0.048, respectively) was associated with CAD. In conditional logistic regression analysis, current abacavir use, current smoking, and hypertension remained significantly associated (aOR = 1.87 [CI = 1.14, 3.07], aOR = 2.31 [1.32, 4.04], and aOR = 10.30 [5.25, 20.20] respectively).

Conclusion

Traditional cardiovascular risk factors and exposure to abacavir were associated with CAD in PLHIV. This study highlights that aggressive management of cardiovascular risk factors remains critical for reducing risk in PLHIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCoronary Artery DiseaseHypertensionHumansMaleMiddle AgedFemaleRisk FactorsAbacavir

Substanzen

Abacavir

Autor:innen und Institutionen

  • Department of Infectious Diseases, Monash University, Melbourne, Vic., Australia.
  • Department of Infectious Diseases, Austin Health, Melbourne, Vic., Australia; and Department of Infectious Diseases at the Peter Doherty Institute of Infection and Immunity, University of Melbourne, Melbourne, Vic., Aus…
  • Department of Infectious Diseases, Monash University, Melbourne, Vic., Australia; and Department of Infectious Diseases, Alfred Hospital, Melbourne, Vic., Australia.
  • Department of Infectious Diseases, Monash University, Melbourne, Vic., Australia; and Life Sciences Discipline, Burnet Institute, Melbourne, Vic., Australia.

Zitieren

APA

Mushin, A. S., Trevillyan, J. M., Lee, S. J., Hearps, A. C., & Hoy, J. F. (2023). Factors associated with the development of coronary artery disease in people with HIV. Sexual Health, 20(5), 470-474. https://doi.org/10.1071/sh23043

Vancouver

Mushin AS, Trevillyan JM, Lee SJ, Hearps AC, Hoy JF. Factors associated with the development of coronary artery disease in people with HIV. Sexual Health. 2023;20(5):470-474. doi:10.1071/sh23043

BibTeX
@article{Mushin2023,
  author = {Mushin, Ari S and Trevillyan, Janine M and Lee, Sue J and Hearps, Anna C and Hoy, Jennifer F},
  title = {Factors associated with the development of coronary artery disease in people with HIV},
  journal = {Sexual Health},
  year = {2023},
  volume = {20},
  number = {5},
  pages = {470--474},
  doi = {10.1071/sh23043}
}
Kostenlos starten →